A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)
Clinical trial NCT02607202 · COMPLETED
Trial details
- NCT number
- NCT02607202
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2021-05-04
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.